Medline Inc Revenue Growth Rates (MDLN), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Medline Inc   (NASDAQ: MDLN)
 

MDLN's Revenue Growth by Quarter and Year

Medline Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/MDLN/growth
https://api.csimarket.com/api/v1/companies/MDLN/fundamentals
https://api.csimarket.com/api/v1/companies/MDLN/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
MDLN Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 7,856.00
2nd Quarter June 7,685.00
1st Quarter March 7,352.00
FY 22,893.00





MDLN Revenue third quarter 2026 Y/Y Growth Comment
Medline Inc reported Revenue increase of 10.41% year on year in the third quarter 2026, to $ 7,856.00 millions, this is lower than Medline Inc 's recent average Revenue increase of 10.89%.
This represents worst decline in recent Company history.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 92 other companies have achieved higher Revenue growth. While Medline Inc ' s Revenue growth of 10.41% ranks overall at the positon no. 1735 in the third quarter 2026.


MDLN Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 10.41 %
2nd Quarter June 11.6 %
1st Quarter March 10.66 %
FY   -

Financial Statements
Medline Inc 's third quarter 2026 Revenue $ 7,856.00 millions MDLN's Income Statement
Medline Inc 's third quarter 2025 Revenue $ 7,115.00 millions Quarterly MDLN's Income Statement


MDLN Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 2.23 %
2nd Quarter June 4.53 %
1st Quarter March -5.59 %
FY (Year on Year)   -


Back to MDLN Growth rate Comparisons >> Back to MDLN Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #93
Healthcare Sector #272
Overall #1735

Revenue Y/Y Growth Statistics
High Average Low
11.6 % 10.89 % 10.41 %
 
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #93
Healthcare Sector #272
Overall #1735
Revenue Y/Y Growth Statistics
High Average Low
11.6 % 10.89 % 10.41 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Medline Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
9.44 % 2.93 % -5.59 %
(Dec 31 2025)  


MDLN's III. Quarter Q/Q Revenue Comment
Medline Inc achieved in the III. Quarter 2026 below company average Revenue growth of 2.23% quarter on quarter, to $ 7,856.00 millions.

Within Medical Equipment & Supplies industry 59 other companies have achieved higher Revenue quarter on quarter growth. While Medline Inc 's Revenue growth quarter on quarter, overall rank is 1483.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #60
Healthcare Sector #199
Overall #1483
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #60
Healthcare Sector #199
Overall #1483
Revenue Q/Q Growth Statistics
High Average Low
9.44 % 2.93 % -5.59 %
(Dec 31 2025)  


MDLN's III. Quarter Q/Q Revenue Comment
Medline Inc achieved in the III. Quarter 2026 below company average Revenue growth of 2.23% quarter on quarter, to $ 7,856.00 millions.

Within Medical Equipment & Supplies industry 59 other companies have achieved higher Revenue quarter on quarter growth. While Medline Inc 's Revenue growth quarter on quarter, overall rank is 1483.


Medline Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 28 2026)		 12 Months Ending (Dec 31 2025) 12 Months Ending 12 Months Ending 12 Months Ending
Cumulative Revenue 12 Months Ending $ 0.00
Y / Y Revenue Growth (TTM) -
Year on Year Revenue Growth Overall Ranking #
Seqeuential Revenue Change (TTM) -
Seq. Revenue Growth (TTM) Overall Ranking #


Cumulative Revenue growth Comment
In the Mar 28 2026 period, Medline Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Medline Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Mar 28 2026 period, Medline Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Medline Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MDLN's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 26 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 26 2026
Supernus Pharmaceuticals inc 18.05%$ 18.047 millions
Outset Medical Inc 17.51%$ 17.510 millions
Alnylam Pharmaceuticals Inc 16.74%$ 16.738 millions
IMPACT BIOMEDICAL INC.16.67%$ 16.667 millions
Rigel Pharmaceuticals Inc16.45%$ 16.452 millions
Si bone inc 16.42%$ 16.424 millions
Ars Pharmaceuticals Inc 16.03%$ 16.027 millions
Atricure Inc 15.84%$ 15.839 millions
Ardelyx inc 15.70%$ 15.704 millions
Novocure Limited15.67%$ 15.666 millions
Penumbra Inc15.64%$ 15.636 millions
Orasure Technologies Inc15.45%$ 15.445 millions
Electromed Inc 15.34%$ 15.342 millions
Irhythm Holdings Inc 15.34%$ 15.339 millions
P3 Health Partners Inc 14.80%$ 14.798 millions
Msa Safety Inc14.72%$ 14.716 millions
Ensign Group Inc14.47%$ 14.471 millions
Abbott Laboratories14.46%$ 14.460 millions
Electrocore Inc 14.40%$ 14.404 millions
Allogene Therapeutics Inc 14.29%$ 14.286 millions
Tandem Diabetes Care Inc 14.26%$ 14.257 millions
Iradimed Corporation14.15%$ 14.154 millions
Apyx Medical Corp14.09%$ 14.093 millions
Incyte Corporation14.00%$ 13.999 millions
Aurinia Pharmaceuticals Inc 13.93%$ 13.926 millions
Indivior Pharmaceuticals Inc 13.74%$ 13.738 millions
Cryoport inc 13.54%$ 13.535 millions
Neuronetics Inc 13.35%$ 13.350 millions
Royalty Pharma Plc13.26%$ 13.263 millions
Evolus Inc 13.23%$ 13.235 millions


About Medline Inc Revenue Growth Rates (MDLN), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Medline Inc (CIK 2046386).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0002046386-26-000063
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Medline Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.